Yale Medicine Hematology has a long and rich tradition of excellence in diagnosing and treating blood disorders. We offer comprehensive clinical care and research programs in both non-malignant and malignant hematologic diseases.

Our nationally and internationally renowned physicians are leaders in their areas of research and clinical expertise, and are committed to understanding the molecular basis of blood disorders and translating scientific discoveries to the clinic.

We offer treatment for all phases and stages of lymphoma, leukemia and myeloma. Although the causes of these cancers remain unknown, advances in treatment, some of which came from research at Yale, are increasing survival rates.

Yale Medicine Hematology has been a leader in the care of hematologic malignancies for several decades, playing a unique role as a regional resource for difficult and challenging cases, with a large number of referrals coming from other hematologists and oncologists in the physician community throughout Connecticut and New England. We work closely with the physicians at Yale Cancer Center both to provide primary care to patients referred for bone marrow transplant who are deemed to be better served by non-transplant treatments, and to provide rapid referral of those patients who are candidates for stem cell transplant.